Global Primary Biliary Cholangitis Market Size To Exceed USD 3.02 Billion by 2035 | CAGR of 10.37% :
Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease in which the body’s immune system gradually destroys the small bile ducts within the liver. This leads to bile buildup, causing liver inflammation and damage. Over time, it may progress to cirrhosis, liver failure, and the need for transplantation.